{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:28:45Z","timestamp":1785796125419,"version":"3.56.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,7,1]]},"DOI":"10.7759\/cureus.41242","type":"journal-article","created":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T07:05:20Z","timestamp":1688195120000},"source":"Crossref","is-referenced-by-count":2,"title":["Immunohistochemical Expression of the Stem Cell Marker CD133 in Colorectal Carcinoma"],"prefix":"10.7759","author":[{"given":"Sweta","family":"Suman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhransu Kumar","family":"Hota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pranati","family":"Misra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nageswar","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subrat","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung H","year":"2021","unstructured":"Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021, 71:209-49. 10.3322\/caac.21660","journal-title":"CA Cancer J Clin"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1038\/s41575-019-0189-8","article-title":"Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies","volume":"16","author":"Keum N","year":"2019","unstructured":"Keum N, Giovannucci E. Global burden of colorectal cancer: emerging trends, risk factors and prevention strategies. Nat Rev Gastroenterol Hepatol. 2019, 16:713-32. 10.1038\/s41575-019-0189-8","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2020.38.15_suppl.e16084","article-title":"Trends in colorectal cancer in India","volume":"38","author":"Thomas VM","year":"2020","unstructured":"Thomas VM, Baby B, Wang K, Lei F, Chen Q, Huang B, Mathew A. Trends in colorectal cancer in India. J Clin Oncol. 2020, 38:10.1200\/JCO.2020.38.15_suppl.e16084","journal-title":"J Clin Oncol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2009.12.064","article-title":"Microsatellite instability in colorectal cancer","volume":"138","author":"Boland CR","year":"2010","unstructured":"Boland CR, Goel A. Microsatellite instability in colorectal cancer. Gastroenterology. 2010, 138:2073-2087.e3. 10.1053\/j.gastro.2009.12.064","journal-title":"Gastroenterology"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2008.07.076","article-title":"Genomic and epigenetic instability in colorectal cancer pathogenesis","volume":"135","author":"Grady WM","year":"2008","unstructured":"Grady WM, Carethers JM. Genomic and epigenetic instability in colorectal cancer pathogenesis. Gastroenterology. 2008, 135:1079-99. 10.1053\/j.gastro.2008.07.076","journal-title":"Gastroenterology"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1038\/nm.4409","article-title":"Cancer stem cells revisited","volume":"23","author":"Batlle E","year":"2017","unstructured":"Batlle E, Clevers H. Cancer stem cells revisited. Nat Med. 2017, 23:1124-34. 10.1038\/nm.4409","journal-title":"Nat Med"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1038\/nm0797-730","article-title":"Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell","volume":"3","author":"Bonnet D","year":"1997","unstructured":"Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med. 1997, 3:730-7. 10.1038\/nm0797-730","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.gendis.2014.09.004","article-title":"The versatile functions of Sox9 in development, stem cells, and human diseases","volume":"1","author":"Jo A","year":"2014","unstructured":"Jo A, Denduluri S, Zhang B, et al.. The versatile functions of Sox9 in development, stem cells, and human diseases. Genes Dis. 2014, 1:149-61. 10.1016\/j.gendis.2014.09.004","journal-title":"Genes Dis"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw235","article-title":"ESMO consensus guidelines for the management of patients with metastatic colorectal cancer","volume":"27","author":"Van Cutsem E","year":"2016","unstructured":"Van Cutsem E, Cervantes A, Adam R, et al.. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016, 27:1386-422. 10.1093\/annonc\/mdw235","journal-title":"Ann Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1136\/jclinpath-2017-204739","article-title":"Cancer stem cells in colorectal cancer: a review","volume":"71","author":"Munro MJ","year":"2018","unstructured":"Munro MJ, Wickremesekera SK, Peng L, Tan ST, Itinteang T. Cancer stem cells in colorectal cancer: a review. J Clin Pathol. 2018, 71:110-6. 10.1136\/jclinpath-2017-204739","journal-title":"J Clin Pathol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1016\/j.clcc.2017.01.011","article-title":"The identifications and clinical implications of cancer stem cells in colorectal cancer","volume":"16","author":"Wahab SM","year":"2017","unstructured":"Wahab SM, Islam F, Gopalan V, Lam AK. The identifications and clinical implications of cancer stem cells in colorectal cancer. Clin Colorectal Cancer. 2017, 16:93-102. 10.1016\/j.clcc.2017.01.011","journal-title":"Clin Colorectal Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V90.12.5002","article-title":"AC133, a novel marker for human hematopoietic stem and progenitor cells","volume":"90","author":"Yin AH","year":"1997","unstructured":"Yin AH, Miraglia S, Zanjani ED, et al.. AC133, a novel marker for human hematopoietic stem and progenitor cells. Blood. 1997, 90:5002-12. 10.1182\/blood.V90.12.5002","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1186\/s40169-018-0198-1","article-title":"The role of CD133 in cancer: a concise review","volume":"7","author":"Glumac PM","year":"2018","unstructured":"Glumac PM, LeBeau AM. The role of CD133 in cancer: a concise review. Clin Transl Med. 2018, 7:18. 10.1186\/s40169-018-0198-1","journal-title":"Clin Transl Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v19.i17.2603","article-title":"CD133: a cancer stem cells marker, is used in colorectal cancers","volume":"19","author":"Ren F","year":"2013","unstructured":"Ren F, Sheng WQ, Du X. CD133: a cancer stem cells marker, is used in colorectal cancers. World J Gastroenterol. 2013, 19:2603-11. 10.3748\/wjg.v19.i17.2603","journal-title":"World J Gastroenterol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.21037\/tcr-22-1277","article-title":"Expression of HIF-1\u03b1, ANXA3, CD133 and their associations with clinicopathological parameters in human colon carcinoma","volume":"11","author":"Chai X","year":"2022","unstructured":"Chai X, Wu X, Ren J, Du K, Wu X, Feng F, Zheng J. Expression of HIF-1\u03b1, ANXA3, CD133 and their associations with clinicopathological parameters in human colon carcinoma. Transl Cancer Res. 2022, 11:1644-51. 10.21037\/tcr-22-1277","journal-title":"Transl Cancer Res"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13051092","article-title":"The role of cancer stem cells in colorectal cancer: from the basics to novel clinical trials","volume":"13","author":"Hervieu C","year":"2021","unstructured":"Hervieu C, Christou N, Battu S, Mathonnet M. The role of cancer stem cells in colorectal cancer: from the basics to novel clinical trials. Cancers (Basel). 2021, 13:10.3390\/cancers13051092","journal-title":"Cancers (Basel)"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1080\/15384047.2019.1599660","article-title":"Colon cancer stem cells: potential target for the treatment of colorectal cancer","volume":"20","author":"Gupta R","year":"2019","unstructured":"Gupta R, Bhatt LK, Johnston TP, Prabhavalkar KS. Colon cancer stem cells: potential target for the treatment of colorectal cancer. Cancer Biol Ther. 2019, 20:1068-82. 10.1080\/15384047.2019.1599660","journal-title":"Cancer Biol Ther"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/5416923","article-title":"Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment","volume":"2018","author":"Phi LT","year":"2018","unstructured":"Phi LT, Sari IN, Yang YG, et al.. Cancer stem cells (CSCs) in drug resistance and their therapeutic implications in cancer treatment. Stem Cells Int. 2018, 2018:5416923. 10.1155\/2018\/5416923","journal-title":"Stem Cells Int"},{"key":"ref19","article-title":"Clinicopathologic significance of high CD133 expression in colorectal carcinomas","volume":"22","author":"Devrim T","year":"2015","unstructured":"Devrim T, Karahan N, Baspinar S, Bozkurt K, Kocer M, Kapucuoglu N. Clinicopathologic significance of high CD133 expression in colorectal carcinomas. Med J SDU. 2015, 22:32-38.","journal-title":"Med J SDU"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3393\/ac.2015.31.3.84","article-title":"Expression of the cancer stem cell markers CD44 and CD133 in colorectal cancer: an immunohisto\u00adchemical staining analysis","volume":"31","author":"Hong I","year":"2015","unstructured":"Hong I, Hong SW, Chang YG, et al.. Expression of the cancer stem cell markers CD44 and CD133 in colorectal cancer: an immunohisto\u00adchemical staining analysis. Ann Coloproctol. 2015, 31:84-91. 10.3393\/ac.2015.31.3.84","journal-title":"Ann Coloproctol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.26717\/BJSTR.2019.22.003801","article-title":"CD133 expression in colon cancer. An immunohistochemical analysis of 72 patients","volume":"22","author":"Pop M","year":"2019","unstructured":"Pop M, Fit A, Bartos D, Vesa A, Puia C, Nadim A, Cornel I. CD133 expression in colon cancer. An immunohistochemical analysis of 72 patients. Biomed J Sci Tech Res. 2019, 22:16917-20. 10.26717\/BJSTR.2019.22.003801","journal-title":"Biomed J Sci Tech Res"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000016709","article-title":"Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma","volume":"98","author":"Park YY","year":"2019","unstructured":"Park YY, An CH, Oh ST, Chang ED, Lee J. Expression of CD133 is associated with poor prognosis in stage II colorectal carcinoma. Medicine (Baltimore). 2019, 98:e16709. 10.1097\/MD.0000000000016709","journal-title":"Medicine (Baltimore)"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.5604\/01.3001.0014.0999","article-title":"High expression of CD133 - stem cell marker for prediction of clinically agressive type of colorectal cancer","volume":"92","author":"Kostovski O","year":"2020","unstructured":"Kostovski O, Antovic S, Trajkovski G, Kostovska I, Jovanovic R, Jankulovski N. High expression of CD133 - stem cell marker for prediction of clinically agressive type of colorectal cancer. Pol Przegl Chir. 2020, 92:9-14. 10.5604\/01.3001.0014.0999","journal-title":"Pol Przegl Chir"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1007\/s40487-022-00205-4","article-title":"Expression and prognostic significance of stem cell marker CD133 in survival rate of patients with colon cancer","volume":"10","author":"Ehteram H","year":"2022","unstructured":"Ehteram H, Aslanbeigi F, Ghoochani Khorasani E, Tolouee M, Haddad Kashani H. Expression and prognostic significance of stem cell marker CD133 in survival rate of patients with colon cancer. Oncol Ther. 2022, 10:451-61. 10.1007\/s40487-022-00205-4","journal-title":"Oncol Ther"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.2258","article-title":"Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma","volume":"15","author":"Choi D","year":"2009","unstructured":"Choi D, Lee HW, Hur KY, et al.. Cancer stem cell markers CD133 and CD24 correlate with invasiveness and differentiation in colorectal adenocarcinoma. World J Gastroenterol. 2009, 15:2258-64. 10.3748\/wjg.15.2258","journal-title":"World J Gastroenterol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/158819-immunohistochemical-expression-of-the-stem-cell-marker-cd133-in-colorectal-carcinoma","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T20:01:25Z","timestamp":1707508885000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/158819-immunohistochemical-expression-of-the-stem-cell-marker-cd133-in-colorectal-carcinoma"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,1]]},"references-count":25,"URL":"https:\/\/doi.org\/10.7759\/cureus.41242","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2023,7,1]]}}}